Publications by authors named "Bondet V"

Objective: Endogenous retroelements (EREs) stimulate type 1 interferon (IFN-I) production but have not been explored as potential interferonogenic triggers in rheumatoid arthritis (RA). We investigated ERE expression in early RA (eRA), a period in which IFN-I levels are increased.

Methods: ERE expression (long terminal repeat [LTR] 5, long interspersed nuclear element 1 [LINE-1], and short interspersed nuclear element [SINE]) in disease-modifying treatment-naïve eRA whole-blood and bulk synovial tissue samples was examined by reverse transcription-polymerase chain reaction and NanoString alongside IFN-α activity.

View Article and Find Full Text PDF

Autoantibodies against cytokines (c-aAb) have been implicated in the pathophysiology of autoimmune diseases, and a variety of infections. In addition, several independent studies have detected elevated titers of c-aAb in the circulation of healthy individuals. To further understand their impact on immune responses, we measured c-aAb against IFN-α, IFN-γ, CSF2, IL-1α, IL-6, and IL-10 in the plasma of 1000 healthy individuals of the Milieu Intérieur (MI) cohort.

View Article and Find Full Text PDF
Article Synopsis
  • HIV infection leads to gastrointestinal mucosal damage, which affects microbial balance and immune response, leading to non-infectious comorbidities in people living with HIV (PLWH).
  • A study measured zonulin levels in serum and intestinal tissue from HIV-infected individuals and controls, revealing higher levels of zonulin in the bloodstream of HIV patients, but lower levels in their gut tissue compared to controls.
  • Elevated systemic zonulin was linked to the loss of intestinal CD4 T cells and increased gut inflammation, suggesting a relationship between zonulin and intestinal health that could be important for managing comorbidities in PLWH.
View Article and Find Full Text PDF
Article Synopsis
  • Hereditary C1q deficiency (C1QDef) is a rare genetic disorder that disrupts the complement system and can cause symptoms similar to systemic lupus erythematosus (SLE).
  • A study of 12 genetically confirmed C1QDef patients showed elevated expression of interferon-stimulated genes and high levels of interferon alpha in their blood and cerebrospinal fluid, indicating significant immune dysfunction.
  • Treatment with Janus-kinase inhibitors had mixed results, with one patient improving while others continued to struggle with their condition, highlighting the complexity of managing C1QDef.
View Article and Find Full Text PDF

Inherited deficiency of the RNA lariat-debranching enzyme 1 (DBR1) is a rare etiology of brainstem viral encephalitis. The cellular basis of disease and the range of viral predisposition are unclear. We report inherited DBR1 deficiency in a 14-year-old boy who suffered from isolated SARS-CoV-2 brainstem encephalitis.

View Article and Find Full Text PDF

Humans display substantial interindividual clinical variability after SARS-CoV-2 infection, the genetic and immunological basis of which has begun to be deciphered. However, the extent and drivers of population differences in immune responses to SARS-CoV-2 remain unclear. Here we report single-cell RNA-sequencing data for peripheral blood mononuclear cells-from 222 healthy donors of diverse ancestries-that were stimulated with SARS-CoV-2 or influenza A virus.

View Article and Find Full Text PDF

Type I IFNs are critical for host responses to viral infection and are also implicated in the pathogenesis of multiple autoimmune diseases. Multiple subtypes exist within the type I IFN family, in particular 13 distinct IFN-α genes, which signal through the same heterodimer receptor that is ubiquitously expressed by mammalian cells. Both evolutionary genetic studies and functional antiviral assays strongly suggest differential functions and activity between the 13 IFN-α subtypes, yet we still lack a clear understanding of these different roles.

View Article and Find Full Text PDF
Article Synopsis
  • Aicardi-Goutières syndrome (AGS) is an immune-mediated disorder primarily affecting the nervous system, and conventional treatments are largely ineffective.
  • A study on JAK1/2 inhibitors showed significant improvement in systemic symptoms of AGS over a median follow-up of 17 months, although neurological benefits were less clear.
  • The findings highlight the need for better treatment strategies for AGS's neurological symptoms, emphasizing early diagnosis and potential intrathecal drug delivery for improved outcomes.
View Article and Find Full Text PDF

Systemic lupus erythematosus (SLE) is characterized by increased expression of type I interferon (IFN)-regulated genes in 50%-75% of patients. We report that out of 501 patients with SLE analyzed, 73 (14%) present autoantibodies against IFNα (anti-IFN-Abs). The presence of neutralizing-anti-IFN-Abs in 4.

View Article and Find Full Text PDF

Tuberculosis (TB) remains a major public health problem and we lack a comprehensive understanding of how () infection impacts host immune responses. We compared the induced immune response to TB antigen, BCG and IL-1β stimulation between latently infected individuals (LTBI) and active TB patients. This revealed distinct responses between TB/LTBI at transcriptomic, proteomic and metabolomic levels.

View Article and Find Full Text PDF

Objective: Myasthenia gravis (MG) is a neuromuscular disease mediated by antibodies against the acetylcholine receptor (AChR). The thymus plays a primary role in AChR-MG and is characterized by a type I interferon (IFN) signature linked to IFN-β. We investigated if AChR-MG was characterized by an IFN-I signature in the blood, and further investigated the chronic thymic IFN-I signature.

View Article and Find Full Text PDF

Introduction: Juvenile systemic lupus erythematosus (j-SLE) is a rare chronic autoimmune disease affecting multiple organs. Ranging from minor features, such as headache or mild cognitive impairment, to serious and life-threatening presentations, j-neuropsychiatric SLE (j-NPSLE) is a therapeutic challenge. Thus, the diagnosis of NPSLE remains difficult, especially in pediatrics, with no specific biomarker of the disease yet validated.

View Article and Find Full Text PDF
Article Synopsis
  • Host immunity to SARS-CoV-2 varies widely, leading to outcomes from asymptomatic infection to severe illness, with some patients showing reduced type I interferon levels before clinical deterioration.
  • Genetic mutations and neutralizing autoantibodies impacting the interferon-I pathway have been identified as risk factors for developing severe COVID-19 pneumonia.
  • In hospitalized patients, there is consistently lower responsiveness of interferon-I proteins upon immune stimulation, suggesting a potential reason for the poor effectiveness of interferon-I treatments in advanced COVID-19 cases, highlighting the need for new therapeutic approaches.
View Article and Find Full Text PDF

Natural resistance to infection is an overlooked outcome after hepatitis C virus (HCV) exposure. Between 1977 and 1979, 1,200 Rhesus D-negative Irish women were exposed to HCV-contaminated anti-D immunoglobulin. Here, we investigate why some individuals appear to resist infection despite exposure (exposed seronegative [ESN]).

View Article and Find Full Text PDF
Article Synopsis
  • The IL-12 family consists of unique cytokines that have various functional roles and the study found a dual response of IL-12p70 to LPS stimulation in healthy individuals.
  • Interferon β (IFNβ) plays a crucial role in promoting IL-12p70 production, and this effect is linked to the levels and activation of circulating monocytes.
  • The findings are clinically relevant, showing that patients with severe SARS-CoV-2 or chronic hepatitis C infections exhibit diminished IFNβ-IL-12p70 responses, which improve once the viral infection is resolved.
View Article and Find Full Text PDF

Objective: Primary Sjögren's syndrome (SS) is the second most frequent systemic autoimmune disease, affecting 0.1% of the general population. To characterize the molecular and clinical variabilities among patients with primary SS, we integrated transcriptomic, proteomic, cellular, and genetic data with clinical phenotypes in a cohort of 351 patients with primary SS.

View Article and Find Full Text PDF
Article Synopsis
  • An interferon gene signature (IGS) is found in about 50% of early rheumatoid arthritis patients and negatively impacts their initial treatment response.
  • A multicenter study with 191 patients confirmed that a higher baseline IGS correlates with increased levels of circulating IFN-α and worse clinical outcomes after six months.
  • The findings suggest that IFN-α triggers harmful immune responses in patients, highlighting the IGS as a potential biomarker for predicting disease severity and the need for targeted therapies.
View Article and Find Full Text PDF

(1) Background: The gut-associated lymphatic tissue (GALT) represents the largest lymphoid organ, and is considered to be the largest HIV reservoir. The exact size of the GALT reservoir remains unclear. Several markers, such as the chemokine receptor CXCR3 and its pro-inflammatory ligand IP-10, have been proposed to define the size of HIV reservoirs in the peripheral blood (PB).

View Article and Find Full Text PDF

NLRP3 inflammasome is suggested to contribute to the complex pathogenesis of systemic lupus erythematosus, but its role in cutaneous lupus erythematosus has not been addressed. This study investigated the expression of NLRP3 inflammasome components and levels of type I interferons in the skin of 20 patients with cutaneous lupus erythematosus. Expression of NLRP1/3, adaptor protein ASC (apoptosis-associated speck-like protein), caspase-1, interferon-α (IFN-α), myxovirus resistance protein (MxA), and interferon-induced proteins 1 and 2 (IFIT 1/2) in the skin was assessed using reverse transcription quantitative real-time PCR (RT-qPCR), western blotting and immunohistochemistry.

View Article and Find Full Text PDF

Objectives: To assess the efficacy and tolerance of the conventional first-line treatment by MTX and CS in patients with JDM regardless of severity.

Methods: We conducted a monocentric retrospective study of patients with newly diagnosed JDM treated with MTX and CS from 2012 to 2020. The proportion of clinically inactive disease (CID) within 6 months of MTX initiation was evaluated using both Paediatric Rheumatology International Trials Organisation (PRINTO) criteria (evaluating muscle inactive disease) and DAS (evaluating skin inactive disease).

View Article and Find Full Text PDF

Both innate and adaptive lymphocytes have critical roles in mucosal defense that contain commensal microbial communities and protect against pathogen invasion. Here we characterize mucosal immunity in patients with severe combined immunodeficiency (SCID) receiving hematopoietic stem cell transplantation (HSCT) with or without myeloablation. We confirmed that pretransplant conditioning had an impact on innate (natural killer and innate lymphoid cells) and adaptive (B and T cells) lymphocyte reconstitution in these patients with SCID and now show that this further extends to generation of T helper 2 and type 2 cytotoxic T cells.

View Article and Find Full Text PDF

Background: Advanced age is accompanied by a decline of immune functions, which may play a role in increased vulnerability to emerging pathogens and low efficacy of primary vaccinations in elderly people. The capacity to mount immune responses against new antigens is particularly affected in this population. However, its precise determinants are not fully understood.

View Article and Find Full Text PDF

Bats are the only mammals with self-powered flight and account for 20% of all extant mammalian diversity. In addition, they harbor many emerging and reemerging viruses, including multiple coronaviruses, several of which are highly pathogenic in other mammals, but cause no disease in bats. How this symbiotic relationship between bats and viruses exists is not yet fully understood.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how the immune response to SARS-CoV-2 impacts the severity of COVID-19, analyzing antibodies, cytokines, and bacterial communities in patients.
  • It finds that high plasma viral load is linked to severe inflammation and the presence of neutralizing antibodies, while nasopharyngeal viral load relates differently to immune responses, showing an inverse relationship with interferon.
  • The research highlights how the nasopharyngeal microbiome influences both local and systemic immunity, which can determine whether COVID-19 outcomes are mild or severe.
View Article and Find Full Text PDF